Is the price fair?
What UNH's price assumes
UnitedHealth Group trades at 25.8× earnings against 25.3× for the median Healthcare Plans name, more expensive than its own group.
25.8
Trailing P/E · Healthcare Plans median 25.3 · 1.02× the median: the market pays up for this one
- Price / sales
- 0.54
Price / sales · as of 2026-Q1
- Free cash flow yield
- 6.5%
Free cash flow yield · Healthcare Plans median 6.5%
- Growth the price implies
- +2.2%
Growth the price implies · The price pays for +2.2% free cash flow growth a year for a decade; the business has delivered −15% a year over the last three.
Details›
- EV / EBIT2026-Q1
- 15.3
- EV / sales2026-Q1
- 0.64
- Healthcare median P/E362 names
- 31.5
- Healthcare Plans median P/E11 names
- 25.3
- Free cash flow, trailing twelve months
- $23.6B
- Market capitalisation
- $364.1B
- 3-year revenue growth
- +8.9%
- 3-year free cash flow growth
- −15%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $274.71 |
| Its own P/E history, median | $303.94 |
| Its own P/E history, upper quartile | $355.79 |
| 52-week range | $238.29 – $436.94 |
| Today | $400.99 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Healthcare Plans
Ranks #10 of 11 by Smart Score